OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis
Patrick O. Perche, Madison K. Cook, Steven R. Feldman
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 1, pp. 86-98
Closed Access | Times Cited: 35
Patrick O. Perche, Madison K. Cook, Steven R. Feldman
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 1, pp. 86-98
Closed Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
An Analysis of Successful Hit-to-Clinical Candidate Pairs
Dean G. Brown
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7101-7139
Closed Access | Times Cited: 26
Dean G. Brown
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7101-7139
Closed Access | Times Cited: 26
Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives
Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 425-425
Open Access | Times Cited: 12
Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 425-425
Open Access | Times Cited: 12
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
Helena Iznardo, Esther Roé, E. Serra‐Baldrich, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 385-385
Open Access | Times Cited: 21
Helena Iznardo, Esther Roé, E. Serra‐Baldrich, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 385-385
Open Access | Times Cited: 21
Janus Kinase Inhibitors and Adverse Events of Acne
Jeremy Martinez, Cyriac Manjaly, Priya Manjaly, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 12, pp. 1339-1339
Closed Access | Times Cited: 19
Jeremy Martinez, Cyriac Manjaly, Priya Manjaly, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 12, pp. 1339-1339
Closed Access | Times Cited: 19
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 279-295
Closed Access | Times Cited: 18
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 279-295
Closed Access | Times Cited: 18
Synthesis of organic solvent‐free nitrogen‐doped carbon quantum dots as unique green fluorimetric probes for analysis of abrocitinib in human plasma
Baher I. Salman, Mohamed A. Abdel‐Lateef, Eman Alzahrani, et al.
Luminescence (2024) Vol. 39, Iss. 6
Open Access | Times Cited: 6
Baher I. Salman, Mohamed A. Abdel‐Lateef, Eman Alzahrani, et al.
Luminescence (2024) Vol. 39, Iss. 6
Open Access | Times Cited: 6
How to get rid of itching
Ashley Vander Does, Teresa Ju, Noreen Mohsin, et al.
Pharmacology & Therapeutics (2023) Vol. 243, pp. 108355-108355
Closed Access | Times Cited: 14
Ashley Vander Does, Teresa Ju, Noreen Mohsin, et al.
Pharmacology & Therapeutics (2023) Vol. 243, pp. 108355-108355
Closed Access | Times Cited: 14
Potential Aspects of the Use of Cytokines in Atopic Dermatitis
Magdalena Krupka, Andrzej Bożek, David Aebisher, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 867-867
Open Access | Times Cited: 5
Magdalena Krupka, Andrzej Bożek, David Aebisher, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 867-867
Open Access | Times Cited: 5
Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea
Ting Zhang, Xu Liu, Lu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Ting Zhang, Xu Liu, Lu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Abrocitinib: A comprehensive review of its use in dermatology beyond atopic dermatitis
Arunima Ray, Deepika Pandhi
Indian Journal of Skin Allergy (2025), pp. 1-18
Closed Access
Arunima Ray, Deepika Pandhi
Indian Journal of Skin Allergy (2025), pp. 1-18
Closed Access
JAK inhibitors as a promising therapy for immune-mediated photodermatoses
Mohammad Malekan, Saeid Taghiloo, Armaghan Kazeminejad, et al.
Drug Discovery Today (2025), pp. 104344-104344
Closed Access
Mohammad Malekan, Saeid Taghiloo, Armaghan Kazeminejad, et al.
Drug Discovery Today (2025), pp. 104344-104344
Closed Access
Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Qin Gao, Yanxia Zhao, Junling Zhang
Heliyon (2023) Vol. 9, Iss. 6, pp. e16704-e16704
Open Access | Times Cited: 12
Qin Gao, Yanxia Zhao, Junling Zhang
Heliyon (2023) Vol. 9, Iss. 6, pp. e16704-e16704
Open Access | Times Cited: 12
Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety
Sama Heidari, Reza Omid, Hanie Babaie, et al.
International Journal of Dermatology (2025)
Closed Access
Sama Heidari, Reza Omid, Hanie Babaie, et al.
International Journal of Dermatology (2025)
Closed Access
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Synthesis and clinical application of small-molecule inhibitors of Janus kinase
Jingyi Zhang, Jinfeng Sun, Peng Nie, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115848-115848
Closed Access | Times Cited: 9
Jingyi Zhang, Jinfeng Sun, Peng Nie, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115848-115848
Closed Access | Times Cited: 9
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
Lalmohan Maji, Sindhuja Sengupta, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Lalmohan Maji, Sindhuja Sengupta, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect
Yi‐Ru Bai, Xin Yang, Ken Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116759-116759
Closed Access | Times Cited: 3
Yi‐Ru Bai, Xin Yang, Ken Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116759-116759
Closed Access | Times Cited: 3
Analysis of publicly available adverse events reported for pediatric patients treated with Janus kinase inhibitors
Sahithi Talasila, Emily Lee, Eric M. Teichner, et al.
Pediatric Dermatology (2024)
Open Access | Times Cited: 2
Sahithi Talasila, Emily Lee, Eric M. Teichner, et al.
Pediatric Dermatology (2024)
Open Access | Times Cited: 2
Neutrophils in Atopic Dermatitis
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 2
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 2
Progress on the Pharmacological Targeting of Janus Pseudokinases
Sean P. Henry, William L. Jorgensen
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10959-10990
Closed Access | Times Cited: 5
Sean P. Henry, William L. Jorgensen
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10959-10990
Closed Access | Times Cited: 5
Comparative efficacy of systemic treatments for atopic dermatitis in adults
Jenna Sesi, Steven R. Feldman
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 313-320
Closed Access | Times Cited: 4
Jenna Sesi, Steven R. Feldman
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 313-320
Closed Access | Times Cited: 4
Revolutionizing the management of patients with atopic dermatitis: practical considerations
Filomena Russo, Anna Rita Giampetruzzi, Maria Pilla, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 213-215
Open Access | Times Cited: 1
Filomena Russo, Anna Rita Giampetruzzi, Maria Pilla, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 213-215
Open Access | Times Cited: 1
Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases
Jingyao Liang, Wei Li, Wenyan Liu, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1793-1797
Open Access | Times Cited: 1
Jingyao Liang, Wei Li, Wenyan Liu, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1793-1797
Open Access | Times Cited: 1
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis
Hui Yu Juan, Shwu‐Jiuan Sheu, De‐Kuang Hwang
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Hui Yu Juan, Shwu‐Jiuan Sheu, De‐Kuang Hwang
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Can Atopic Dermatitis and Allergic Contact Dermatitis Coexist?
J R Johnson
Cutis (2021) Vol. 110, Iss. 3
Open Access | Times Cited: 10
J R Johnson
Cutis (2021) Vol. 110, Iss. 3
Open Access | Times Cited: 10
